Gastrointestinal Cancer
Conference Coverage
Elevated liver cancer risk after HCV cure may justify surveillance
Sustained virologic response in patients with well controlled hepatic C virus infection does not protect select subgroups of this cohort from...
Conference Coverage
High SVR achieved in decompensated HCV patients with 12-week therapy
The findings are encouraging because current treatment options for patients with HCV who have decompensated liver disease are limited, Dr....
Conference Coverage
VIDEO: PALBI score sharpened liver cancer prognosis
News
Pan-AKT inhibitor shrinks tumors in patients with AKT1 mutation
A novel pan-AKT inhibitor shrinks tumors in patients harboring a mutation in AKT1.
Conference Coverage
Lusutrombopag is effective for thrombocytopenia in liver disease
Key clinical point: In a phase III trial, lusutrombopag was found to reduce the need for platelet transfusion in chronic liver disease patients...
Conference Coverage
ACS: Watchful waiting for some rectal cancers almost ready for ‘prime time’
Key clinical point: Organ preservation seems to be a valid option when locally advanced rectal cancers respond completely to neoadjuvant therapy....
Conference Coverage
Expert outlines priorities for colorectal cancer biomarkers
News
ASTRO: Novel adjuvant approach ‘encouraging’ for pancreatic cancer
Key clinical point: Stereotactic body radiation therapy used with a novel tumor cell vaccine and a dose-modified FOLFIRINOX regimen represents a...
Conference Coverage
ACS: No clear answers to black patients’ worse rectal cancer outcomes
Median survival was 109.6 months among white patients and 85.8 months among black patients with rectal cancer.
Conference Coverage
Transcription factor loss linked to worse colorectal cancer outcomes
In colorectal cancer arising in the hindgut, loss of SMAD4 is associated with worse recurrence-free survival.
Commentary
Commentary: Red meat and cancer risk – what your patients should know
The WHO’s classification of processed meat as a carcinogen and red meat as a probable carcinogen could help motivate patients to make healthier...